Janice Jhang on Policy & Market Forces Driving Biosimilar Adoption

Subscribe to UnitedHealthcare's Community & State newsletter. Health Affairs' Editor-in-Chief Alan Weil interviews Janice Jhang of Harvard University about her recent paper that explores how regulatory and market forces are driving adoption of biosimilars. Order the November 2024 issue of Health Affairs. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone. Subscribe to UnitedHealthcare's Community & State newsletter.